eMIMS New Product
Ciproxin licensed for UTI in children
23-Jun-08
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line
treatment of complicated UTIs and pyelonephritis in children and adolescents aged between 1-17 years.
The dose is 10-20mg/kg orally every 12 hours up to a maximum of 750mg per dose. The recommended duration of treatment is 10-21 days.
Further information: Bayer plc 01635 563000
Quick search - use * for an abbreviated search, eg nico*
Tools
Related Articles
Related Fact Sheets
Related Drugs By Area
Related Clinical Ask the Expert
Latest Guidelines
- Osteoporotic Fragility Fractures in Postmenopausal Women: Primary Prevention (NICE)
- Osteoporotic Fragility Fractures in Postmenopausal Women: Secondary Prevention (NICE)
- VTE, Prevention of: Dabigatran (NICE)
- Influenza Prophylaxis: Oseltamivir, Amantadine and Zanamivir (NICE)
- Hepatitis B, Chronic: Entecavir (NICE)
GMS Contract Action Plan
Jobs
Job of the Week
- Full Time / Part Time Salaried GPs Yorkshire and Humberside
- Salaried Doctor East of England
- Salaried General Practitioner(s) East Midlands
- Partner East of England
- Partner Yorkshire and Humberside
- Salaried GP North West England
- salaried GP/retainer North West England
- Medical Partnership in Ireland Republic of Ireland
- Part -Time Salaried GP Yorkshire and Humberside
- Full Time Salaried GP Yorkshire and Humberside
Comments
Only registered users may comment. Log in now or register for a free account.